<DOC>
	<DOCNO>NCT02262650</DOCNO>
	<brief_summary>Study investigate relative bioavailability concomitant administration clopidogrel telmisartan ( Test 1 ) relative bioavailability SR26334 alone ( Reference 1 ) , relative bioavailability telmisartan alone ( Reference 2 ) . And investigate bioavailability SR26334 follow administration clopidogrel 30 minute intake telmisartan ( Test 2 ) relative bioavailability SR26334 alone ( Reference 1 ) , relative bioavailability telmisartan alone ( Reference 2 )</brief_summary>
	<brief_title>Relative Bioavailability Telmisartan SR26334 After Co-administration Compared Bioavailability Telmisartan SR26334 After Administration Telmisartan Clopidogrel Alone Healthy Male Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Healthy male female subject accord follow criterion : base upon complete medical history , physical examination , vital sign ( BP , HR ) , 12lead ECG , clinical laboratory test Signed date write informed consent prior admission study accordance Good Clinical Practice ( GCP ) local legislation Age &gt; = 40 year Body Mass Index ( BMI ) &gt; =18.5 &lt; =29.9 kg/m2 Good venous status forearm Any find medical examination ( include blood pressure , heart rate , electrocardiogram ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial Use drug , might reasonably influence result trial base knowledge time protocol preparation within 10 day prior administration trial Participation another trial investigational drug within two month prior administration trial Smoker ( 10 cigarette three cigar three pipes/day ) Alcohol abuse ( 60 g/day ) Drug abuse Blood donation loss 400 mL within four week prior administration trial . Excessive physical activity ( within five day prior administration trial ) Any laboratory value outside reference range clinical relevance History hereditary fructose intolerance Veins unsuited i.v . puncture either arm ( e.g . vein difficult locate , access puncture , vein tendency rupture puncture , etc . ) Inability comply dietary regimen study centre Inability comply investigator instruction For female subject : Pregnancy Positive pregnancy test No adequate contraception e.g . oral contraceptive , sterilization , intrauterine device ( IUD ) Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>